Cargando…
Inactivation of tumor suppressor gene Clusterin leads to hyperactivation of TAK1-NF-κB signaling axis in lung cancer cells and denotes a therapeutic opportunity
Purpose: Clinical success of precision medicine is severely limited by de novo or acquired drug resistance. It remains a clinically unmet need to treat these patients. Tumor suppressor genes (TSGs) play a critical role in tumorigenesis and impact the therapeutic effect of various treatments. Experim...
Autores principales: | Chen, Zhipeng, Fan, Zhenzhen, Dou, Xiaowei, Zhou, Qian, Zeng, Guandi, Liu, Lu, Chen, Wensheng, Lan, Ruirui, Liu, Wanting, Ru, Guoqing, Yu, Lei, He, Qing-Yu, Chen, Liang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ivyspring International Publisher
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7545994/ https://www.ncbi.nlm.nih.gov/pubmed/33052230 http://dx.doi.org/10.7150/thno.44829 |
Ejemplares similares
-
A tumor suppressor enhancing module orchestrated by GATA4 denotes a therapeutic opportunity for GATA4 deficient HCC patients
por: Lu, Feng, et al.
Publicado: (2020) -
GATA6 Exerts Potent Lung Cancer Suppressive Function by Inducing Cell Senescence
por: Chen, Wensheng, et al.
Publicado: (2020) -
Neuronal Hyperactivation in EEG Data during Cognitive Tasks Is Related to the Apolipoprotein J/Clusterin Genotype in Nondemented Adults
por: Ponomareva, Natalya V., et al.
Publicado: (2023) -
Targeting hyperactive TGFBR2 for treating MYOCD deficient lung cancer
por: Zhou, Qian, et al.
Publicado: (2021) -
Blocking interaction between SHP2 and PD‐1 denotes a novel opportunity for developing PD‐1 inhibitors
por: Fan, Zhenzhen, et al.
Publicado: (2020)